Solid Tumor (FFPE_ Liquid Biopsy ctDNA )

Home/NGS Clinical Services/Solid Tumor (FFPE_ Liquid Biopsy ctDNA )

Project Description

DNA analysis of solid Tumors (FFPE samples / Liquid Biopsy cfDNA )

ALK, BRAF, EGFR, KRAS, NRAS somatic-gene region sequencing. CE-IVD . 

Includes FDA & EU approved therapies: Afatinib, Cetuximab, Dabrafenib, Erlotinib, Gefitinib, Panitumumab, Trametinib, Vemurafenib.

  • ALK, KRAS, BRAF, EGFR somatic-gene region variants from FFEP or DNA samples. Includes analysis report on regions ERBB2, ERBB4, FGFR1, FGFR2, FGFR3, MET, DDR2, PIK3CA, AKT1, PTEN, NRAS, MAP2K1, STK11, NOTCH1, CTNNB1, SMAD4, FBXW7, TP53
  • New chemical sequencing solution for false-positives
  • Bio-data Report: identification & analysis of variants
  • The final clinical will available via secure down-load
  • Total processing time is estimated between 15 and 30 days according to the size of the samples

 

DNA & RNA analysis of solid tumors (FFPE samples)

Human somatic regions variants sequencing and sequencing of fusion transcripts. CE-IVD. ALK, BRAF, EGFR, KRAS, NRAS somatic-gene region sequencing. 

Includes FDA & EU approved therapies: Ceritinib, Crizotinib, Afatinib, Cetuximab, Dabrafenib, Erlotinib, Gefitinib, Panitumumab, Trametinib, Vemurafenib.

 

  • Trascript-fusion Sequencing of the ALK, ROS-1, RET and NTRK genes associated with solid tumours.
  • ALK, KRAS, BRAF, EGFR somatic-gene region variants from FFEP or DNA samples. Includes analysis report on regions ERBB2, ERBB4, FGFR1, FGFR2, FGFR3, MET, DDR2, PIK3CA, AKT1, PTEN, NRAS, MAP2K1, STK11, NOTCH1, CTNNB1, SMAD4, FBXW7, TP53
  • FFEP samples possible using only 10ng RNA
  • New chemical sequencing solution for false-positives.
  • Detection & recording of low frequency variats (SNPs, InDels) in RNA libraries as well as fusion transcripts in RNA libraries
  • The final clinical will available via secure down-load
  • Total processing time is estimated between 15 and 30 days according to the size of the samples

 

Genetracer is prepared to allow first-time customers a success-based free-pilot of its Solid Tumor service. Please contact us for more details.

Certificate of External Quality Assessment Scheme for Lung Cancer

Genetracer Biotech (Lung Scheme)
 

Project Details

Categories: